The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...

The Food and Drug Administration (FDA) has recently released two draft guidance documents (Artificial Intelligence-Enabled Device Software ...

“In 2025, expect AI, fueled by new GenAI-enabled capabilities, to chip away at gains in efficiency, accuracy, and speed ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

BioSpace recaps 2024’s top venture capital rounds in biopharma, from Xaira Therapeutics’ blockbuster $1B raise to ...

QuantHealth can now perform real-time simulations and deploy its AI models to the point of care, “unlocking new opportunities and use cases” for its pharma customers, Inbar declared.

The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...

HUNTINGTON, N.Y., Jan. 10, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical ("Sen-Jam"), a pioneer in innovative inflammatory care, today announced a planned new initiative for use of leading-edge AI ...

About Viz.ai Viz.ai is the pioneer in the use of AI algorithms and machine ... delivers significant value to patients, providers, and pharmaceutical and medical device companies.

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...